Skip to content
Screener

Immix Biopharma, Inc. IMMX Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$0
AbbVie logo
AbbVieABBV
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$721.15M+982%
Enterprise value$642.94M+1,047%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 5:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-021764
Line itemMarch 31, 2026December 31, 2025
Commitments and contingencies--
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding-
Common stock, $0.0001 par value; 200,000,000 shares authorized; 53,084,455 shares issued and 53,012,092 shares outstanding at March 31, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 20255,3075,301
Additional paid-in capital198,903,047198,293,956
Accumulated other comprehensive income105,63660,160
Accumulated deficit(114,549,971)(104,463,284)
Treasury stock at cost, 72,363 shares as of March 31, 2026 and December 31, 2025(99,963)(99,963)

Document

FAQ

What is Immix Biopharma, Inc.'s common stock, par value (in dollars per share)?
Immix Biopharma, Inc. (IMMX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has Immix Biopharma, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
Immix Biopharma, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Immix Biopharma, Inc.'s common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.

Ask your AI about Immix Biopharma, Inc.'s common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude